Prior Movesmirror the world’s best investors
Preview. Tables on this page show their first five rows. Sign in if you subscribe, or see what Pro includes.

VEEV: who owns it, and who’s predicted to buy next

Veeva Systems Inc-Class A · Information Technology · on the Prior Moves forward board for 2026-09-30 at rank #66. Research, not investment advice.

75 PriorScorelast close $296.133m momentum 50.5%

Predicted to buy next quarter

1 tracked investor ranks VEEV in the top tenth of their own model’s candidates for 2026-09-30, strongest first. This is a forecast about a later filing, not a confirmation that anyone has bought the security or a recommendation to do so.

Strongest ranked investor signal: Chris Hohn. No calibrated purchase probability is shown.

Currently disclosed holders

No investor in our tracked set discloses VEEV in their latest 13F. The prediction above is a forward call, not a mirror of current holdings.

Mutual fund and ETF holders

437 US mutual funds and ETFs from 188 fund families reported a position in VEEV for the quarter ending 2026-06-30. Against their own report a quarter earlier, 101 raised shares, 145 opened a new position, 129 cut and 94 sold out. Source: SEC Form N-PORT, which funds file about 60 days after quarter end. Share counts, not trades: a change can reflect fund inflows rather than a decision about VEEV.

Fund familyFundsShare of fund-held shares
Vanguard Index Funds641.1%
Ishares Trust1611.9%
T. Rowe Price Mid-Cap Growth Fund, Inc.14.4%
Vaneck Etf Trust24.3%
Ab Large Cap Growth Fund Inc13.2%
Select Sector Spdr Trust12.9%
Vanguard Institutional Index Funds22.4%
T. Rowe Price U.S. Large-Cap Core Fund, Inc.12.3%
The weekly digest

The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.

See the full ranked board on top picks, how the PriorScore is built on how it works, the honest edge numbers on methodology, and the running accuracy on the prediction leaderboard. Forward quarter 2026-09-30, data as of 2026-10-17. Research, not investment advice, see the disclaimer.